- The Federal Trade Commission is said unlikely to challenge Amazon's ( NASDAQ: AMZN ) planned acquisition of One Medical ( NASDAQ: ONEM ) as there don't appear to be any business overlaps or vertical issues.
- The only issue the antitrust regulator may have is Amazon's ( AMZN ) size, though the FTC likely won't have any real theory to stop a transaction, according to a Dealreporter item earlier, which cited sources familiar.
- One source said the deal is like Amazon's recent purchase of MGM, which the FTC didn't like, but there was nothing it could really do about the deal, Dealreporter said.
- Amazon ( AMZN ) agreed to purchase One Medical ( ONEM ), an operator of a membership-based primary care platform for nearly $3.9B, the companies announced on Thursday.
For further details see:
FTC said unlikely to be able to challenge Amazon's planned One Medical purchase